A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

January 4, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Alzheimer's Disease
Interventions
DRUG

AL002

Administered via intravenous (IV) infusion

Trial Locations (54)

2113

KaRa Institute of Neurological Disease, Macquarie Park

3004

Alfred Health, Melbourne

3128

Box Hill Hospital, Box Hill

8028

Fundacion ACE Instituto Catalan de Neurociencias-Gran via de Carles III, 85 bis, Barcelona

11030

Feinstein Institute For Medical Research, Manhasset

12200

Ambulantes Gesundheitszebtrum der Charite GmbH, Berlin

13125

Charité - Universitätsmedizin Berlin, Berlin

13210

SUNY Upstate Medical Center, Syracuse

13875

ASL Biella - Ospedale degli Infermi, Ponderano

20007

Georgetown University Medical Center, Washington D.C.

20009

Fundacion CITA Alzheimer Fundazioa, San Sebastián

20122

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan

20133

Fondazione IRCCS Di Rilievo Nazionale Istituto Nazionale Neurologico Carlo Besta-VIA MANGIAGALLI 3, Milan

25123

ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia - INCIPIT - PIN, Brescia

25125

IRCCS - Centro S. Giovanni di Dio Fatebene fratelli, Brescia

28034

Hospital Universitario Ramon y Cajal, Madrid

32127

Progressive Medical Research - ClinEdge - PPDS, Port Orange

32159

Charter Research, Lady Lake

32751

K2 Medical Research - Maitland, Maitland

32819

Conquest Research LLC - Winter Park - ClinEdge - PPDS, Winter Park

33449

"Alzheimers Research and Treatment Center-Wellington ", Wellington

33487

SFM Clinical Research, LLC, Boca Raton

33609

Axiom Brain Health LLC, Tampa

39401

Hattiesburg Clinic, Hattiesburg

41126

Azienda Ospedaliero-Universitaria di Modena - Policlinico di Modena, Modena

45219

University of Cincinnati Medical Center, Cincinnati

46017

Hospital Universitario Doctor Peset, Valencia

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

48993

Centro De Atencion Especializada Oroitu, Getxo

50012

Hospital Viamed Montecanal, Zaragoza

81675

Klinikum rechts der Isar der Technischen Universitaet Muenchen, Munich

85006

Banner Alzheimer's Institute, Phoenix

89081

Universitätsklinikum Ulm-Oberer Eselsberg 45, Ulm

97210

Summit Research Network, Portland

07753

Advanced Clinical Institute, Neptune City

X5004AOA

Instituto Privado Kremer, Córdoba

05500

Centro de Psiquiatria Biologica, Mendoza

K9H 2P4

Kawartha Regional Memory Clinic, Peterborough

M6A 2X8

Baycrest Health Sciences, Toronto

00168

Fondazione Policlinico Universitario A Gemelli-Rome, Rome

00185

Azienda Policlinico Umberto, Rome

00186

Ospedale Isola Tiberina - Gemelli Isola, Rome

Unknown

Azienda Ospedaliero Universitaria Pisana, Pisa

5223 LA

Brain Research Center Den Bosch - PPDS, 's-Hertogenbosch

53-110

NZOZ Wroclawskie Centrum Alzheimerowskie, Wroclaw

01-684

Centrum Medyczne NeuroProtect, Warsaw

70-111

EUROMEDIS Sp. z o.o., Szczecin

08025

Hospital de La Santa Creu i Sant Pau, Barcelona

PL6 8BT

RE: Cognition Health - Plymouth, Plymouth

GU2 7YD

Re:Cognition Health - Guildford - PPDS, Guildford

BS32 4SY

Re-Cognition Health - Bristol, Bristol

W1G 9RU

Re:Cognition Health, London

WC1N 3BG

The National Hospital for Neurology and Neurosurgery, London

ML1 4UF

NeuroClin Glasgow, Motherwell

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Alector Inc.

INDUSTRY